NextRNA Therapeutics Funding: $56M Raised, Series A (2022)
NextRNA Therapeutics is based in Boston. It has raised $56M in total funding. Latest round: Series A.
NextRNA Therapeutics funding overview
NextRNA Therapeutics is based in Boston. NextRNA Therapeutics has raised $56M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2022. The round record for NextRNA Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Cobro Ventures, Lightchain Capital, Circle Alternative Investments, Evans Capital Management, Jefferies LLC, Rivas Capital and 2 others. 8 distinct backers are named across the disclosed rounds.
NextRNA Therapeutics at a glance
Total raised
$56M
Latest round
Series A
Latest round date
August 2022
Headquarters
Boston
Notable investors
Cobro Ventures, Lightchain Capital, Circle Alternative Investments, Evans Capital Management, Jefferies LLC, Rivas Capital, Willett Advisors, Drew Dennison
Frequently asked about NextRNA Therapeutics funding
How much has NextRNA Therapeutics raised?
NextRNA Therapeutics has raised $56M in total disclosed funding across the rounds on record.
Who has invested in NextRNA Therapeutics?
Cobro Ventures, Lightchain Capital, Circle Alternative Investments, Evans Capital Management, Jefferies LLC, Rivas Capital are named among the investors backing NextRNA Therapeutics.
What was the latest NextRNA Therapeutics funding round?
The most recent disclosed round is a Series A, announced in August 2022.
Where is NextRNA Therapeutics based?
NextRNA Therapeutics is based in Boston.
When did NextRNA Therapeutics last raise?
The last disclosed NextRNA Therapeutics round closed in August 2022 at Series A.
Totals shown for NextRNA Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Boston and the investors behind them below.
